Overview

EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2)

Status:
Not yet recruiting
Trial end date:
2021-07-31
Target enrollment:
Participant gender:
Summary
This is an double-blind, randomized, placebo controlled phase III study in hospitalized subjects with confirmed SARS-CoV-2.
Phase:
Phase 3
Details
Lead Sponsor:
S.L.A. Pharma AG